Oncologic and Reproductive Outcomes of Uterine Smooth Muscle Tumor of Uncertain Malignant Potential: A Single Center Retrospective Study of 67 Cases

被引:19
|
作者
Huo, Lanqing [1 ]
Wang, Dan [1 ]
Wang, Wenze [2 ]
Cao, Dongyan [1 ]
Yang, Jiaxin [1 ]
Wu, Ming [1 ]
Yang, Junjun [1 ]
Xiang, Yang [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Obstet & Gynecol, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Pathol, Beijing, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2020年 / 10卷
关键词
smooth muscle tumor; uncertain malignant potential; surgical procedure; recurrence; reproductive outcomes; LEIOMYOSARCOMAS; LEIOMYOMAS; EXPRESSION; VARIANTS; STUMP; P16; P53;
D O I
10.3389/fonc.2020.00647
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The term "uterine smooth muscle tumor of uncertain malignant potential" (STUMP) indicates a rare tumor that cannot be classified as a benign leiomyoma or malignant leiomyosarcoma. In this study, we assessed the clinical characteristics, fertility, and oncologic outcomes of patients diagnosed as STUMP in 14 years. In addition, we analyzed the risk factors for recurrence in patients with STUMP. Methods: Medical records of STUMP patients at Peking Union Medical College Hospital (PUMCH) between January 2005 and June 2019 were reviewed and analyzed. Disease-free survival, age of diagnosis, tumor size, surgical procedure, pathology and immunohistochemistry, clinical characteristics, recurrence rate, and reproductive outcomes in the follow-up period were assessed. Univariate and multivariate analyses were performed to determine the prognostic factors. Results: The median age was 42 years old (range: 21-63). Total hysterectomy with or without bilateral salpingo-oophorectomy was performed in 29/67 cases (43.3%), and myomectomy was performed in 38/67 cases (56.7%). Ten patients experienced recurrences, and all but two recurrences occurred within 5 years after the initial surgery. Only two of these recurrences were leiomyosarcoma. There were no deaths in themedian follow-up period of 48.4 (range 2.6-170.2) months. There were no remarkable differences in location of tumor between the myomectomy and hysterectomy groups, but the patients in the myomectomy group were younger than those in the hysterectomy group. In univariate and multivariate analysis, mitosis on pathology was the only independent risk factor for recurrence. Expression of Ki-67, p53, and p16 was significantly higher in patients with recurrence. Seven of the 35 patients who attempted to conceive had successful pregnancies. Conclusions: The prognosis of STUMP was favorable and tumors with more than 10 mitoses per 10 high power field should be monitored closely. The surgical procedure was not an independent risk factor of recurrence, and myomectomy may be an acceptable option for patients wishing to preserve fertility.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Clinical and reproductive outcomes of uterine smooth muscle tumor of uncertain malignant potential: a single-center retrospective study
    Ning, Chengcheng
    Zhang, Lihong
    Zhao, Chenyan
    Chen, Xiaojun
    Liu, Xiaoxia
    Gu, Chao
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2021, 49 (04)
  • [2] Uterine smooth muscle tumors of uncertain malignant potential (STUMP): A retrospective study in a single center
    Zhang, Chen
    Gao, Juan
    Lu, Shanshan
    Zhang, Yinli
    Zhu, Honglan
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2021, 265 : 74 - 79
  • [3] A RETROSPECTIVE STUDY OF UTERINE SMOOTH MUSCLE TUMOR OF UNCERTAIN MALIGNANT POTENTIAL (USTUMP): AN ANALYSIS OF 19 CASES
    Gu, C.
    Chen, X.
    Ning, C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A170 - A170
  • [4] Uterine smooth muscle tumor of uncertain malignant potential: A retrospective analysis
    Guntupalli, Saketh R.
    Ramirez, Pedro T.
    Anderson, Matthew L.
    Milam, Michael R.
    Bodurka, Diane C.
    Malpica, Anais
    GYNECOLOGIC ONCOLOGY, 2009, 113 (03) : 324 - 326
  • [5] Uterine Smooth Muscle Tumor of Uncertain Malignant Potential: A Retrospective, Monocentric Cohort Study
    Ettore, Carla
    Incognito, Giosue Giordano
    Gulino, Ferdinando Antonio
    Russo, Emanuele
    Cannone, Francesco
    Ettore, Giuseppe
    SURGERIES, 2023, 4 (03): : 412 - 419
  • [6] Uterine Smooth Muscle Tumor of Uncertain Malignant Potential: Clinicopathologic Study of 45 Cases
    Srivastava, Sucheta
    Moench, Laura
    Longacre, Teri A.
    LABORATORY INVESTIGATION, 2016, 96 : 311A - 311A
  • [7] Uterine Smooth Muscle Tumor of Uncertain Malignant Potential: Clinicopathologic Study of 45 Cases
    Srivastava, Sucheta
    Moench, Laura
    Longacre, Teri A.
    MODERN PATHOLOGY, 2016, 29 : 311A - 311A
  • [8] Uterine smooth muscle tumor of uncertain malignant potential
    da Silva, A. C.
    Calapodopulos, T.
    Guaresqui, T. C.
    Saldanha, J. C.
    Murta, E. F. C.
    Nomelini, R. S.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2019, 40 (06) : 1070 - 1072
  • [9] Uterine smooth muscle tumor of uncertain malignant potential: fertility and clinical outcomes
    Sahin, Hanifi
    Karatas, Funda
    Coban, Gonca
    Ozen, Ozlem
    Erdem, Ozlem
    Onan, Mehmet Anil
    Ayhan, Ali
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2019, 30 (04)
  • [10] “The Uncertain and Unpredictable”: Uterine Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP)—Three Cases
    Joseph D.
    Chitrathara K.
    Indian Journal of Gynecologic Oncology, 2018, 16 (3)